-
Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy.
Journal article
Varley J. et al, (2018), Neuropharmacology, 132, 71 - 82
-
Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
Journal article
Wilson R. et al, (2018), Brain, 141, 1063 - 1074
-
N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications.
Journal article
Makuch M. et al, (2018), Ann Neurol, 83, 553 - 561
-
The importance of early immunotherapy in patients with faciobrachial dystonic seizures.
Journal article
Thompson J. et al, (2018), Brain, 141, 348 - 356
-
Bortezomib for Neuromyelitis Optica Spectrum Disorder: A New Therapeutic Option for the More Severe Forms?
Journal article
Taylor J. and Irani SR., (2018), JAMA Neurol, 75
-
Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.
Journal article
Balint B. et al, (2018), Brain, 141, 13 - 36
-
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.
Journal article
Binks S. et al, (2017), Journal of Neurology, Neurosurgery and Psychiatry
-
Psychosis: an autoimmune disease?
Journal article
Al-Diwani AAJ. et al, (2017), Immunology, 152, 388 - 401
-
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.
Journal article
Binks SNM. et al, (2017), J Neurol Neurosurg Psychiatry
-
Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.
Journal article
Hyun J-W. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 811 - 817